EPISODE · Jun 2, 2023 · 17 MIN
Biotech M&A Booms, But Have Buyouts Reached a Tipping Point?
In the latest episode of Pathfinders, Senior Biotechnology Analyst Gregory Renza discusses what’s driving the latest spate of biotech M&A activity — the new players and partnership dynamics that are creating what he calls “a landscape of competition” in the broader market.
Embed this episode
NOW PLAYING
Biotech M&A Booms, But Have Buyouts Reached a Tipping Point?
0:00
17:04
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Pathfinders in Biopharma?
This episode is 17 minutes long.
When was this Pathfinders in Biopharma episode published?
This episode was published on June 2, 2023.
Can I download this Pathfinders in Biopharma episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!